A Canadian-based marijuana company showed itself to be a bit of a unicorn last week, after posting a profit at a time when so many of its peers are hemorrhaging cash and struggling to survive through the deadly coronavirus pandemic.
According to its financials, the cannabis grower saw its revenues for the three-month period that ended Feb. 29 reach C$144.4 million (US$101.95), almost double the C$73.6 million (US$51.96 million) in the same period in the previous year. Furthering the good news for investors was the fact the company showed it had just over C$515 million (US$363.59) in cash on its books.
However, Aphria opted to suspend its outlook for the rest of year due to the uncertainty caused by the COVID-19 health crisis.
Aphria Weekly Price Chart
The earnings report sent the company’s stock straight up, gaining almost 10%. It has since backtracked on those gains as it seesawed throughout most of the rest of last week. Aphria stock edged down more than 4% yesterday to close at US$3.44 (C$4.82).
There has been a lot written about how pot stocks have been pummelled since the latter half of 2019. Investors have been battered and bruised as growers stumbled along the road to profitability. Many have yet to make it to that destination and continue to struggle.
As a measure of just how rough a road it has been for investors, consider this: at roughly this time last year, 17 cannabis companies of the more than 300 publicly traded companies in the sector on both sides of the Canada-U.S. border boasted market caps of US$1 billion (C$1.4 billion) or more. Today, there are only seven.
And although they still hover above the billion-dollar threshold, these companies have suffered significant losses in overall value. Here is a quick rundown of how they’re faring:
- Canopy Growth (NYSE:CGC), (TSX:WEED) remains the biggest player in the field by market cap. This Ontario-based grower has a market cap of US$5.28 billion (C$7.49 billion). Although still the biggest, it has lost more than 64% of its value in the last year.
- GW Pharmaceuticals (NASDAQ:GWPH) is a UK-based company that is traded on the NASDAQ. It focuses on cannabinoid prescription medicines. It has a market cap of US$3.17 billion (C$4.5 billion). Its stock has lost about 32% in the last year.
- Cronos Group (NASDAQ:CRON), (TSX:CRON) is another Canadian based company traded both on the S&P/TSX Composite in Toronto and the NASDAQ. It has a market cap of US$2.07 billion (C$2.94 billion). It has lost just over 61% of its value in the last year.
- Massachusetts-based Curaleaf Holdings (OTC:CURLF), (CSE:CURA) has a market cap of US$1.88 billion (C2.67 billion), having lost more than 62% of its value in the last year.
- Green Thumb Industries (OTC:GTBIF), (CSE:GTII) is a Chicago-based national cannabis consumer retailer and packager with a market cap of US$1.21 billion (C$1.72 billion).
- Innovative Industrial Properties Inc (NYSE:IIPR) is a real estate investment trust for the medical cannabis industry and based in California. It has a market cap of US$1.25 billion (C$1.77 billion). Over the last year, its shares have lost just over 11% of their value.
- Trulieve Cannabis (OTC:TCNNF), (CSE:TRUL) is the largest medical marijuana company in Florida, with a market cap of US$1.03 billion (C$1.46 billion). In the last year its stock has lost about 35.5% of its value.
Aphria Pulls Out A Rare Cannabis Sector Win After Posting A Profit
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.